Animal Science Products, Inc., et al., v. Hebei Welcome Pharmaceutical Co. Ltd., et al.
Issues
Is a court bound to defer to a foreign government’s interpretation of its domestic law when appearing before the court?
This case will decide whether American courts are bound to accept a foreign government’s interpretation of its own laws. Animal Science Products Inc. (“Animal Science Products”) argues that a “binding deference standard”, which requires courts to accept an appearing foreign government’s description of its laws, inhibits a court’s ability to independently reach an accurate determination of foreign law. Furthermore, Animal Science contends, the lower court’s decision to uphold binding deference misapplied the Supreme Court’s holding in United States v. Pink. Hebei Welcome Pharmaceuticals (“Hebei”) counters that requiring courts to accept an appearing foreign government’s reasonable statement of its laws appropriately balances judicial independence and international comity concerns. Moreover, Hebei asserts that the court below was correct in finding United States v. Pink to support binding deference. This issue affects how federal courts interpret foreign law in international litigation. Accordingly, this case will impact international litigation strategy and entities with operations that are regulated outside of the U.S.
Questions as Framed for the Court by the Parties
Whether a court may exercise independent review of an appearing foreign sovereign’s interpretation of its domestic law (as held by the Fifth, Sixth, Seventh, Eleventh, and D.C. Circuits), or whether a court is “bound to defer” to a foreign government’s legal statement, as a matter of international comity, whenever the foreign government appears before the court (as held by the opinion below in accord with the Ninth Circuit).
In 2005, Animal Science Products, Inc. and various Vitamin C producers in the United States (“Animal Science Products”) filed suit in the Eastern District of New York against Hebei Welcome Pharmaceuticals Co. (“Hebei”), a Chinese pharmaceutical company and its holding company, alleging that Hebei was a co-conspirator who established an illegal cartel for price-fixing purposes. Animal Science Products, Inc., et al. v. Hebei Welcome Pharmaceutical Co. Ltd., et al., 837 F.3d 175, 179 (2d Cir. 2016) at 5–6.
Edited by
Additional Resources
- Jonathan M. Barnett, SCOTUS is about to hear the easiest antitrust case ever, The Hill (March 31, 2018).
- Alison Frankel, DOJ Bucks China, urges SCOTUS to hear case against vitamin cartel, Reuters (Nov. 17, 2017).